Production (Stage)
InterCure Ltd.
INCR
$1.52
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 60.60K | 4.65M | 9.33M |
| Total Depreciation and Amortization | -- | -- | 899.30K | 2.95M | 3.63M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 1.01M | 633.30K | -1.26M |
| Change in Net Operating Assets | -- | -- | -16.84M | -9.23M | -12.42M |
| Cash from Operations | -- | -- | -14.87M | -996.30K | -728.20K |
| Capital Expenditure | -- | -- | -194.80K | -2.76M | -3.96M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -1.40M | -4.99M | -4.86M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -2.48M | -25.21M | -34.03M |
| Cash from Investing | -- | -- | -4.08M | -32.96M | -42.85M |
| Total Debt Issued | -- | -- | 9.80M | 152.21M | 251.26M |
| Total Debt Repaid | -- | -- | -65.03M | -125.62M | -187.49M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -4.12M | -21.69M | -21.41M |
| Cash from Financing | -- | -- | -16.80M | 1.83M | 13.04M |
| Foreign Exchange rate Adjustments | -- | -- | 27.20K | -404.20K | 1.69M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -35.73M | -32.53M | -28.85M |